Greener NHS - 18/11/2024 National Health Service working towards climate neutrality The National Health Service (NHS) in the United Kingdom and Northern Ireland is taking steps to become more environmentally sustainable. The NHS has committed to the ambitious goal of achieving net zero carbon emissions by 2040, aiming to significantly reduce its climate impact in the coming years.https://www.gesundheitsindustrie-bw.de/en/article/news/national-health-service-working-towards-climate-neutrality
Event - 28/11/2024 Venture Capital Meet & Greet - Catalpa Ventures Online, Webinar https://www.gesundheitsindustrie-bw.de/en/event/venture-capital-meet-und-greet-catalpa-ventures
Press release - 15/11/2024 Selenium proteins as a possible new target for cancer research An important enzyme helps the body produce selenium proteins – this discovery could open up new strategies for treating cancer in children. This has been published by scientists from the University of Würzburg, the University Sao Paolo, the German Cancer Research Center (DKFZ) and the Heidelberg Stem Cell Institute HI-STEM*.https://www.gesundheitsindustrie-bw.de/en/article/press-release/selenium-proteins-possible-new-target-cancer-research
Press release - 15/11/2024 Patient association raises 10,000 euros for work on PURA syndrome - Donation for research into rare neuronal developmental disorder at Ulm University PURA syndrome is a rare developmental disorder of the brain for which there is currently no cure. The patient association PURA Syndrome Germany was founded last year. Since then, the affected families have been collecting donations with great dedication – and have decided to donate the majority of this money to research into the syndrome at Ulm University. https://www.gesundheitsindustrie-bw.de/en/article/press-release/patient-association-raises-10000-euros-work-pura-syndrome-donation-research-rare-neuronal-developmental-disorder-ulm-university
Press release - 14/11/2024 Novel method for fighting tumors Making existing cancer therapy more efficient while significantly reducing the side effects on healthy tissue - this is the aim of a project at Aalen University. It is being funded with one million euros from the Carl Zeiss Foundation. The biophysicist and his team are developing innovative nanoparticles made of gold. The particles use radiotherapy and chemotherapy simultaneously and kill the cancer cells in a targeted manner.https://www.gesundheitsindustrie-bw.de/en/article/press-release/novel-method-for-fighting-tumors
Advancing quantum technology into real-world applications - 06/11/2024 QSens: BMBF future cluster brings quantum sensors of the future into medicine The BMBF-funded future cluster ‘QSens – Quantum Sensors of the Future’ is developing ultra-sensitive sensors that could open up new options in medicine, enabling faster drug research, more accurate diagnostics and improved rehabilitation. The universities of Stuttgart and Ulm are actively working with 17 industry partners to put these cutting-edge innovations to immediate practical use.https://www.gesundheitsindustrie-bw.de/en/article/news/qsens-bmbf-future-cluster-brings-quantum-sensors-future-medicine
Press release - 05/11/2024 How biomedical innovation improves preclinical research 3D tumor models, simulations of drug responses or plant stems used for testing heart stents: the 3R-BioMedicUS center at the University of Stuttgart is developing innovative biomedical approaches to improve preclinical studies, to be seen in the new video.https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-biomedical-innovation-improves-preclinical-research
Press release - 05/11/2024 Heidelberg scientist receives highly endowed EC synergy grant Heidelberg scientist Dr Venera Weinhardt has received an ERC Synergy Grant for a pioneering biomedical research project. The European Research Council (ERC) is granting this funding to advance soft X-ray microscopy. This imaging technique along with other innovations will be used to investigate the hepatitis E virus. https://www.gesundheitsindustrie-bw.de/en/article/press-release/heidelberg-scientist-receives-highly-endowed-ec-synergy-grant
Press release - 30/10/2024 Diabetes switch in DNA: Non-coding region in the genome influences ONECUT1 gene They are underestimated genetic control elements: it is known that changes in the genome can trigger diabetes. But now researchers at the University Hospital Ulm and the INSERM Cochin Institute in Paris have shown that a previously under-researched region of the genome also plays a crucial role in the development of this disease. https://www.gesundheitsindustrie-bw.de/en/article/press-release/diabetes-switch-dna-non-coding-region-genome-influences-onecut1-gene
NMI project WOUNDSENS - 23/10/2024 Wound monitoring using sensory nanofibres Monitoring the condition of chronic, non-healing wounds requires wound dressings to be changed at short, regular intervals. In the EU-funded WOUNDSENS project, researchers at the NMI in Reutlingen are using electrospinning to produce novel types of wound dressings. These consist of biosensory fibres that send information about the condition of the wound to the outside, thereby improving inflammation detection.https://www.gesundheitsindustrie-bw.de/en/article/news/wound-monitoring-using-sensory-nanofibres
Press release - 16/10/2024 Sensitive Arm Prostheses A quantum sensor that can register nerve impulses without contact opens up new possibilities in prosthetics. Researchers at Fraunhofer IPA are developing together with the industrial partner Q.ANT the prototype of one Prosthetic arm that is controlled by neural commands like healthy limbs.https://www.gesundheitsindustrie-bw.de/en/article/press-release/sensitive-arm-prostheses
Sustainable medical technology - 10/10/2024 Rethinking plastics in medical technology Good healthcare relies heavily on medical products made from plastic. However, the widespread use of synthetic materials, particularly disposable items, creates vast amounts of waste, depletes resources and leads to a substantial carbon footprint. To create more environmentally friendly plastic products in the future, substantial changes to production processes are essential.https://www.gesundheitsindustrie-bw.de/en/article/news/rethinking-plastics-medical-technology
Press release - 09/10/2024 Language model "UroBot“ surpasses the accuracy of experienced urologists Scientists at the German Cancer Research Center (DKFZ), together with doctors from the Urological Clinic of the Mannheim University Hospital, have developed and successfully tested a chatbot based on artificial intelligence. "UroBot" was able to answer questions from the urology specialist examination with a high degree of accuracy, surpassing both other language models and the accuracy of experienced urologists. https://www.gesundheitsindustrie-bw.de/en/article/press-release/language-model-urobot-surpasses-accuracy-experienced-urologists
Event - 13/11/2024 Networking Evening BW-UK | MEDICA 2024 MEDICA trade-fair, Baden-Württemberg joint-booth H09, Hall 14, Registration deadline: 08/11/2024, Messe https://www.gesundheitsindustrie-bw.de/en/event/networking-abend-bw-uk-medica-2024
Press release - 01/10/2024 Reporter Skin: In-vitro Skin Makes Cell Reaction to Test Substance Measurable in Real Time At the Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB, a three-dimensional skin model has now been set up for the first time that directly displays the skin's reaction to substances: The reporter skin. Thanks to the built-in reporter, the cellular response can be measured precisely and quickly – using a living model. https://www.gesundheitsindustrie-bw.de/en/article/press-release/reporter-skin-vitro-skin-makes-cell-reaction-test-substance-measurable-real-time
Press release - 25/09/2024 How do rare genetic variants affect health? AI provides more accurate predictions Whether we are predisposed to particular diseases depends to a large extent on the countless variants in our genome. However in the case of genetic variants the influence on the presentation of certain pathological traits has been difficult to determine. Researchers have introduced an algorithm based on deep learning that can predict the effects of rare genetic variants. https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-do-rare-genetic-variants-affect-health-ai-provides-more-accurate-predictions
Chronic inflammatory bowel diseases - 25/09/2024 Proinflammatory regulatory T lymphocytes as a therapeutic target in Crohn's disease Chronic inflammatory bowel diseases are very stressful for those affected and increase the risk of bowel cancer. PD Dr. Robyn Laura Kosinsky from the Bosch Health Campus in Stuttgart, together with researchers from the USA, identified disfunctional regulatory T cells as important drivers of inflammation in Crohn's disease. They also found that with the help of an epigenetically active drug, it was possible to restore the cells’ original…https://www.gesundheitsindustrie-bw.de/en/article/news/proinflammatory-regulatory-t-lymphocytes-therapeutic-target-crohns-disease
Press release - 25/09/2024 How developmental signals can contribute to Genomic Mosaicism Certain developmental signals play a significant role in maintaining our genetic blueprints. They prevent alterations in the genome, known as mosaicism. The underlying biological mechanism helps the DNA to produce an identical copy of itself during cell division using the original genetic blueprint. However, it can also contribute to genomic mosaicism during nerve cell development.https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-developmental-signals-can-contribute-genomic-mosaicism
Press release - 23/09/2024 Carl Zeiss Foundation supports early career research group for biohybrid neuroimplants Dr Simon Binder has been awarded a five-year, 1.5 million euro grant from the Carl Zeiss Foundation for his research into novel neuroimplants. Binder will establish the early career research group ‘Biohybrid Neuroimplants based on Soft Hydrogel Electrodes’ at the University of Freiburg. It is affiliated with the research institutions BrainLinks-BrainTools.https://www.gesundheitsindustrie-bw.de/en/article/press-release/carl-zeiss-foundation-supports-early-career-research-group-biohybrid-neuroimplants
Press release - 19/09/2024 Quality standards for looking into the tumor genome Personalized medicine with individually tailored therapies is becoming more a reality in cancer. This requires a look into the genetic material of tumors, a molecular diagnostic tumor profile. A research group from the German Network for Personalized Medicine (DNPM) has recorded the quality standards according to which genome analyses are carried out in Germany. The data is a prerequisite for integrating gene sequencing into routine care. https://www.gesundheitsindustrie-bw.de/en/article/press-release/quality-standards-looking-tumor-genome
Press release - 18/09/2024 Future cluster QSens starts the second round of funding In the “Cluster4Future” QSens of the Universities of Stuttgart and Ulm, scientists, companies and start-ups are researching quantum sensors with a wide range of potential applications. The Federal Ministry of Education and Research is funding QSens for a further three years as part of “Clusters4Future”.https://www.gesundheitsindustrie-bw.de/en/article/press-release/future-cluster-qsens-starts-second-round-funding
Press release - 17/09/2024 Five new cross-border doctoral networks at Universität Heidelberg Five transnational and cross-institutional doctoral networks at Heidelberg University are being funded as part of the “Marie Skłodowska-Curie Actions”. They work together on current scientific topics with high innovation potential. Ruperto Carola coordinates an MSCA Doctoral Network on artificial intelligence in physics, two networks in medicine, life sciences and engineering. https://www.gesundheitsindustrie-bw.de/en/article/press-release/five-new-cross-border-doctoral-networks-universitat-heidelberg
Press release - 12/09/2024 Power-to-vitamins: microbes produce folate from simple basic ingredients Biotechnology team at University of Tübingen obtains valuable byproduct in protein production. This could be a potential to the contribution of feeding a growing world population without livestock farming.https://www.gesundheitsindustrie-bw.de/en/article/press-release/power-vitamins-microbes-produce-folate-simple-basic-ingredients
Press release - 11/09/2024 Researchers combine the power of artificial intelligence and the wiring diagram of a brain to predict brain cell activity Scientists have long sought ways to simulate the neural networks in the brain with computers in order to understand how it works. Now, researchers have combined new measurements of the wiring diagrams of the fruit fly with artificial intelligence methods to build a neural network that can do what few thought possible: To predict the activity of individual neurons without making a single measurement in a living brain. https://www.gesundheitsindustrie-bw.de/en/article/press-release/researchers-combine-power-artificial-intelligence-and-wiring-diagram-brain-predict-brain-cell-activity
BIOPRO Baden-Württemberg publishes first results of a new WifOR study - 11/09/2024 Industrial healthcare industry in Baden-Württemberg: gross value added of more than 19 billion euros The industrial healthcare sector (iGW) plays a central role in the economy in Baden-Württemberg. In 2021, the sector generated a direct gross value added of 19.6 billion euros, which corresponds to around a third (32.6%) of the entire regional healthcare industry. Of 96.3%, almost all of the healthcare sectors's exports in the state in 2021 came from the iGW. These are the findings of a new study conducted on behalf of BIOPRO…https://www.gesundheitsindustrie-bw.de/en/article/press-release/industrial-healthcare-industry-baden-wuerttemberg-gross-value-added-more-19-billion-euros